U.S. Physical Therapy, Inc. Fundamental Analysis (NYSE: USPH)
U.S. Physical Therapy, Inc. Fundamental Analysis (NYSE: USPH)
U.S. Physical Therapy, Inc. (NYSE: USPH) shows weak financial fundamentals with a PE ratio of 464.35, profit margin of -0.77%, and ROE of -1.27%. The company generates $0.8B in annual revenue with strong year-over-year growth of 16.33%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze USPH's fundamental strength across five key dimensions:
Efficiency Score
WeakUSPH struggles to generate sufficient returns from assets.
Valuation Score
ModerateUSPH shows balanced valuation metrics.
Growth Score
ModerateUSPH shows steady but slowing expansion.
Financial Health Score
ExcellentUSPH maintains a strong and stable balance sheet.
Profitability Score
WeakUSPH struggles to sustain strong margins.
Key Financial Metrics
Is USPH Expensive or Cheap?
P/E Ratio
USPH trades at 464.35 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, USPH's PEG of -5.02 indicates potential undervaluation.
Price to Book
The market values U.S. Physical Therapy, Inc. at 2.65 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.38 times EBITDA. This is generally considered low.
How Well Does USPH Make Money?
Net Profit Margin
For every $100 in sales, U.S. Physical Therapy, Inc. keeps $-0.77 as profit after all expenses.
Operating Margin
Core operations generate 10.81 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.27 in profit for every $100 of shareholder equity.
ROA
U.S. Physical Therapy, Inc. generates $-0.48 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
U.S. Physical Therapy, Inc. produces operating cash flow of $83.87M, showing steady but balanced cash generation.
Free Cash Flow
U.S. Physical Therapy, Inc. produces free cash flow of $64.70M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $4.25 in free cash annually.
FCF Yield
USPH converts 5.34% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
464.35
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-5.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.65
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.54
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.86
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.27
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.01
vs 25 benchmark
ROA
Return on assets percentage
-0.00
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How USPH Stacks Against Its Sector Peers
| Metric | USPH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 464.35 | 31.70 | Worse (Expensive) |
| ROE | -1.27% | 448.00% | Weak |
| Net Margin | -0.77% | 22837.00% | Weak |
| Debt/Equity | 0.86 | 0.54 | Weak (High Leverage) |
| Current Ratio | 1.27 | 5.63 | Neutral |
| ROA | -0.48% | -49.00% (disorted) | Weak |
USPH outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews U.S. Physical Therapy, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
56.17%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-58.32%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-36.51%
Industry Style: Defensive, Growth, Innovation
Declining